Evidence map›Paper›PMID 38838477›Full record

Trial reportDrug and alcohol dependence2024

Project phoenix: Pilot randomized controlled trial of a smartphone-delivered intervention for people who are not ready to quit smoking.

Michael S Businelle, Lizbeth Benson, Emily T Hébert, Jordan Neil, Darla E Kendzor, Summer Frank-Pearce, Krista M Kezbers, Damon Vidrine, Akshay Gaur

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Drug and alcohol dependence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03405129 (Project Phoenix), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03405129 nacompletednot on this map

Project Phoenix: Pilot Intervention for Smokers Who Are Not Ready to Quit Smoking

TypeinterventionalSponsorUniversity of OklahomaRan2018 to 2022Enrolled152ConditionsSmoking Cessation, MotivationArmsPhoenix, NRT order button, Factoid
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael S BusinelleTSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, USA; Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: Michael-Businelle@ouhsc.edu.
Lizbeth BensonTSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, USA.
Emily T HébertDepartment of Health Promotion and Behavioral Sciences, UT Health School of Public Health, Austin, TX, USA.
Jordan NeilTSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, USA; Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Darla E KendzorTSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, USA; Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Summer Frank-PearceTSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, USA; College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Krista M KezbersTSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, USA.
Damon VidrineDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
Akshay GaurTSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, USA.

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ROBERT S. MANNEL · 2018 to 2026
$27.1M
Using Machine Learning to Develop Just-in-Time Adaptive Interventions for Smoking CessationR00DA046564 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HEBERT, EMILY TAYLOR · 2021 to 2023
$747k
NCI NIH HHS P30 CA225520NIDA NIH HHS R00 DA046564
6 · The paper itself

Abstract

backgroundMost people who smoke cigarettes report they want to quit in the future, but only 20 % are ready to quit within the next 30 days. This 3-arm pilot randomized controlled trial examined the feasibility and initial efficacy of a novel smartphone-based intervention that aimed to induce smoking cessation attempts among adults not initially ready to quit.

methodsParticipants randomized into the two intervention groups (Group 1: Phoenix App Only; Group 2: Phoenix App + Nicotine Replacement Therapy) received daily smoking cessation messages via smartphone application that were tailored to their current readiness to quit, while the attention control group (i.e., Factoid) received messages not related to smoking cessation. All participants completed a weekly survey for 26 weeks and used the app to set quit dates when/if desired.

resultsParticipants (N=152) were female (67.8 %), White (75.7 %), 50.0 years old (SD=12.5), and smoked 20.4 cigarettes per day (SD=10.5). Results indicated that the Phoenix interventions were feasible (e.g., participants viewed ~185 messages over 26 weeks; 74.8 % of weekly surveys were completed; 85.5 % completed the 26-week follow-up assessment). Phoenix participants set more quit dates, set quit dates sooner, were abstinent for more days, and used smoking cessation medications on more days than those assigned to the Factoid group.

conclusionsThis low-burden, smartphone-based smoking cessation induction intervention may increase smoking cessation attempts, and may reduce barriers that are encountered with traditional in-person or call-based interventions.

trial registrationClinicaltrials.gov number: NCT03405129; https://clinicaltrials.gov/ct2/show/NCT03405129.

Indexed as

SmartphoneSmoking CessationAdultFemaleHumansMaleMiddle AgedMobile ApplicationsPilot ProjectsTobacco Use Cessation DevicesEcological momentary assessmentJust in time adaptive interventionMobile healthSmartphoneSmoking cessationSmoking cessation inductionTobacco

Identifiers

PMID38838477
PMCPMC11179962

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.